CUE vs ES · rev $9.3M vs P/E 28, rev $11.90B
Cue Biopharma (CUE) versus Eversource Energy (ES) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Eversource Energy (ES) is a utilities - regulated electric company listed on US.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported ES revenue for 2024-12-31 was $11.90B. Net income was $819.2M. Revenue was down 0.1% from 2023-12-31 to 2024-12-31. ES currently screens at market cap $23.72B and trailing P/E 28.3.
CUE currently screens at market cap $59.5M. ES currently screens at market cap $23.72B and trailing P/E 28.3.
Not investment advice. Open the CUE and ES stock pages for the full models.
Not investment advice.